Radiopharm Theranostics is developing a world-class platform of radiopharmaceutical and nuclear medicine products for both diagnostic and therapeutic uses.
Company Details
- Employees
- 21
- Founded
- -
- Address
- Sydney, Au
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- nuclearmedicine, therapeutic, diagnostics, biotechnology, biotech, cancerresearch, cancer, clinicaltrials, medtech, health, radioactivedrugs, drugdiscovery, breastcancer, lungcancer, neckcancer, pancreaticcancer, braincancer, glioblastoma, peptides, smallmolecules, monoclonalantibodies, antibodies, breastcancerimaging, patients, HER2, radiopharmaceuticals, therapeutics.
- HQ
- Sydney
Radiopharm Theranostics Questions
Radiopharm Theranostics's website is http://www.radiopharmtheranostics.com
Radiopharm Theranostics's LinkedIn profile is https://au.linkedin.com/company/radiopharm-theranostics
Radiopharm Theranostics has
21 employees.
View email and phone details for 21
employees at Radiopharm Theranostics.
Radiopharm Theranostics's industry is
Biotechnology Research
Radiopharm Theranostics's top competitors are
Lantheus,
Nucleus Radiopharma,
Jubilant Radiopharma,
Ratio Therapeutics,
Fusion Pharmaceuticals,
Atomvie Global Radiopharma Inc.,
Clarity Pharmaceuticals,
Curium Pharma,
Point Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company,
Telix Pharmaceuticals Limited.
Radiopharm Theranostics's categories are Biotechnology Research
Radiopharm Theranostics's founding year is 2021
